Envoy Medical Inc (COCH)

$0.65 -0.04 (-6.19%)
Market Cap 19.96M
Revenue (ttm) 230,000.00
Net Income (ttm) -20.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,043.48%
Debt to Equity Ratio 0.00
Volume 193,100
Avg Vol 792,048
Day's Range N/A - N/A
Shares Out 28.79M
Stochastic %K 5%
Beta 2.08
Analysts Sell
Price Target $7.75

Company Profile

Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy...

Industry: Medical Devices
Sector: Healthcare
Phone: 877 900 3277
Address:
4875 White Bear Parkway, White Bear Lake, United States
KuJonas
KuJonas Mar. 4 at 11:01 AM
$COCH New watcher here... Pretty silent forum 🧐 Massive insider purchases over February and a trial expected to end late March 2026.. For me, pretty bullish, but why is it so quiet?
1 · Reply
BillionerOfKing
BillionerOfKing Feb. 28 at 3:19 AM
$COCH Current Stock Price: $0.71
0 · Reply
nshootz
nshootz Feb. 27 at 9:26 PM
$COCH Looking ofrward to the future here
0 · Reply
nshootz
nshootz Feb. 25 at 3:51 PM
$COCH Today: Bullish cross on Daily chart (9 SMA>50 SMA)
1 · Reply
David_M_
David_M_ Feb. 24 at 1:05 PM
$COCH
0 · Reply
newsfile_corp
newsfile_corp Feb. 24 at 1:01 PM
https://nfne.ws/285020 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #NASDAQ #Investing
0 · Reply
GuruChartist
GuruChartist Feb. 23 at 5:11 PM
$COCH Envoy Medical Fireside Chat Date: Wednesday, February 25, 2026 Time: 10:00 AM ET Webinar Registration Link: https://ir.envoymedical.com/news-events/ir-calendar Lot of "'splaining" to do.
0 · Reply
newsfile_corp
newsfile_corp Feb. 23 at 1:00 PM
https://nfne.ws/284835 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #Patent #NASDAQ #Investing
0 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 12:38 PM
$MENS $EDRY $COCH $MGRX ••
0 · Reply
TheWayISeeIt
TheWayISeeIt Feb. 23 at 5:44 AM
$NWBO FYI $COCH and $COSM have seen some large insider buys. On the watchlist…
0 · Reply
Latest News on COCH
Envoy Medical Regains Compliance with Nasdaq Listing Requirement

Feb 24, 2026, 8:00 AM EST - 10 days ago

Envoy Medical Regains Compliance with Nasdaq Listing Requirement

Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space

Feb 23, 2026, 8:00 AM EST - 11 days ago

Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space

Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

Feb 19, 2026, 8:00 AM EST - 15 days ago

Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Feb 17, 2026, 8:00 AM EST - 17 days ago

Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering

Feb 12, 2026, 4:05 PM EST - 22 days ago

Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering

Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5

Jan 29, 2026, 8:35 AM EST - 5 weeks ago

Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5

Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Dec 18, 2025, 8:00 AM EST - 2 months ago

Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant

Dec 10, 2025, 8:00 AM EST - 3 months ago

Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant

Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

Dec 4, 2025, 8:00 AM EST - 3 months ago

Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient

Envoy Medical Announces the Grant of Its 40th U.S. Patent

Dec 2, 2025, 8:00 AM EST - 3 months ago

Envoy Medical Announces the Grant of Its 40th U.S. Patent

Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

Nov 20, 2025, 8:00 AM EST - 3 months ago

Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery

Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Nov 10, 2025, 8:00 AM EST - 4 months ago

Envoy Medical Reports Third Quarter 2025 Financial and Operational Results

Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Nov 4, 2025, 8:00 AM EST - 4 months ago

Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial

Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

Oct 29, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant

Envoy Medical Receives Positive Listing Determination from NASDAQ

Oct 27, 2025, 8:00 AM EDT - 4 months ago

Envoy Medical Receives Positive Listing Determination from NASDAQ

Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 9, 2025, 4:05 PM EDT - 5 months ago

Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 8, 2025, 7:00 AM EDT - 5 months ago

Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 7, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Oct 7, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical Receives FDA Approval to Advance Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data

Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th

Oct 1, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 25, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Sep 24, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sep 22, 2025, 8:00 AM EDT - 5 months ago

Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Sep 19, 2025, 8:00 AM EDT - 6 months ago

Envoy Medical Expands Patent Portfolio by Securing Additional European Patent for Breakthrough Cochlear Implant Technology

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Sep 10, 2025, 8:00 AM EDT - 6 months ago

Envoy Medical Issues Letter to Shareholders and Provides Update on Recent Accomplishments

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Sep 9, 2025, 8:00 AM EDT - 6 months ago

Envoy Medical Secures Four New Global Patents, Expanding Its Leadership Position in Fully Implantable Hearing Technology

Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025

Sep 8, 2025, 8:00 AM EDT - 6 months ago

Envoy Medical to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-10, 2025

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Sep 3, 2025, 8:00 AM EDT - 6 months ago

Envoy Medical Successfully Reaches Three-Month Follow-Up Milestone in Clinical Trial of the Acclaim Fully Implanted Cochlear Implant

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Aug 26, 2025, 8:00 AM EDT - 6 months ago

Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

Aug 20, 2025, 8:00 AM EDT - 7 months ago

Envoy Medical Secures Three New Patents, Strengthening Leadership in Fully Implantable Hearing Technology

Envoy Medical Reports on Second Quarter 2025 Results

Jul 31, 2025, 8:00 AM EDT - 7 months ago

Envoy Medical Reports on Second Quarter 2025 Results

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

Jul 8, 2025, 8:00 AM EDT - 8 months ago

Envoy Medical Expands Patent Portfolio with New Issuances in the United States

Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

Jul 1, 2025, 8:00 AM EDT - 8 months ago

Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia

New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical

Jun 26, 2025, 8:00 AM EDT - 9 months ago

New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for Envoy Medical

Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

Jun 11, 2025, 8:30 AM EDT - 9 months ago

Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up

Jun 10, 2025, 8:30 AM EDT - 9 months ago

Envoy Medical's Pivotal Clinical Trial for Fully Implanted Acclaim(R) Cochlear Implant Remains On Track After First Month Follow-Up

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

May 13, 2025, 9:15 AM EDT - 10 months ago

Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial

Envoy Medical Reports on First Quarter 2025 Results

May 1, 2025, 4:30 PM EDT - 11 months ago

Envoy Medical Reports on First Quarter 2025 Results

EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies

Apr 22, 2025, 6:00 AM EDT - 11 months ago

EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 31, 2025, 9:15 AM EDT - 1 year ago

Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Mar 17, 2025, 9:25 AM EDT - 1 year ago

Hearing Device Coverage Clarification Act Reintroduced in House and Senate

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Mar 12, 2025, 9:00 AM EDT - 1 year ago

Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device

Envoy Medical to Participate in the 37th Annual ROTH Conference

Mar 10, 2025, 9:00 AM EDT - 1 year ago

Envoy Medical to Participate in the 37th Annual ROTH Conference

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Feb 24, 2025, 9:25 AM EST - 1 year ago

First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Feb 14, 2025, 9:15 AM EST - 1 year ago

Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Dec 19, 2024, 9:00 AM EST - 1 year ago

Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Nov 14, 2024, 8:38 AM EST - 1 year ago

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

Envoy Medical's Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Nov 12, 2024, 9:25 AM EST - 1 year ago

Envoy Medical's Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Nov 8, 2024, 9:25 AM EST - 1 year ago

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

Nov 1, 2024, 8:00 AM EDT - 1 year ago

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

KuJonas
KuJonas Mar. 4 at 11:01 AM
$COCH New watcher here... Pretty silent forum 🧐 Massive insider purchases over February and a trial expected to end late March 2026.. For me, pretty bullish, but why is it so quiet?
1 · Reply
BillionerOfKing
BillionerOfKing Feb. 28 at 3:19 AM
$COCH Current Stock Price: $0.71
0 · Reply
nshootz
nshootz Feb. 27 at 9:26 PM
$COCH Looking ofrward to the future here
0 · Reply
nshootz
nshootz Feb. 25 at 3:51 PM
$COCH Today: Bullish cross on Daily chart (9 SMA>50 SMA)
1 · Reply
David_M_
David_M_ Feb. 24 at 1:05 PM
$COCH
0 · Reply
newsfile_corp
newsfile_corp Feb. 24 at 1:01 PM
https://nfne.ws/285020 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #NASDAQ #Investing
0 · Reply
GuruChartist
GuruChartist Feb. 23 at 5:11 PM
$COCH Envoy Medical Fireside Chat Date: Wednesday, February 25, 2026 Time: 10:00 AM ET Webinar Registration Link: https://ir.envoymedical.com/news-events/ir-calendar Lot of "'splaining" to do.
0 · Reply
newsfile_corp
newsfile_corp Feb. 23 at 1:00 PM
https://nfne.ws/284835 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #Patent #NASDAQ #Investing
0 · Reply
6GodEnergy
6GodEnergy Feb. 23 at 12:38 PM
$MENS $EDRY $COCH $MGRX ••
0 · Reply
TheWayISeeIt
TheWayISeeIt Feb. 23 at 5:44 AM
$NWBO FYI $COCH and $COSM have seen some large insider buys. On the watchlist…
0 · Reply
BigTimePennyStocks
BigTimePennyStocks Feb. 22 at 6:33 PM
Small-Caps with Catalysts this week: 👇👇 ( $ORKT, $COCH, $BNGO, $ERNA, etc...) #NASDAQ #NYSE
0 · Reply
David_M_
David_M_ Feb. 22 at 2:12 AM
$COCH Monday we find out.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 21 at 11:28 AM
$COCH RSI: 53.17, MACD: 0.0026 Vol: 0.10, MA20: 0.62, MA50: 0.68 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
eneub87
eneub87 Feb. 20 at 3:37 PM
$COCH
0 · Reply
VishalMathew
VishalMathew Feb. 19 at 6:32 PM
$COCH Can Envoy satisfy the $35M market value requirement for Nasdaq compliance by Feb 23, 2026 deadline? Will SEC give extension? Looks like their market value changed only on Feb 12 ,2026 which means they only satisfied $35M market value for only 6 days instead of 10.
1 · Reply
DARKP00L
DARKP00L Feb. 19 at 1:31 PM
$COCH 08:07 on Feb. 19 2026 Envoy Medical Issues Update Highlighting Recent Financing, Noting Further Positive Clinical Trial Progress, And Announcing Upcoming Fireside Chat #tradeideas
0 · Reply
newsfile_corp
newsfile_corp Feb. 19 at 1:02 PM
https://nfne.ws/284437 $COCH @envoymedical #Chemicals #Biotechnology #HealthCare #Financing #NASDAQ #Investing
0 · Reply
David_M_
David_M_ Feb. 18 at 8:51 PM
$COCH
0 · Reply
MRFOREXDAYTRADER
MRFOREXDAYTRADER Feb. 18 at 7:27 PM
$COCH Imminent news incoming
1 · Reply
Geo_Scene
Geo_Scene Feb. 18 at 3:52 PM
$COCH quietly climbing $SNSE wish didn’t sell ya at $12 green is green 🤷‍♂️
0 · Reply
AliciaNester280
AliciaNester280 Feb. 18 at 1:15 PM
$COCH Early-stage biotech with binary risk.
0 · Reply
SadyK189
SadyK189 Feb. 18 at 2:19 AM
Top Stocks to watch tomorrow 2 / 2: $SAGT $VVPR $OLB $COCH $LGHL OLB: Alerted at 0.47 yesterday. After making a nice run to 1.78 it fell to key support zone of 0.89 - 0.99 now. It may bounce off this support zone to test 1.4 - 1.6 zone again. COCH: Getting up on daily chart. Key support zone at 0.54 - 0.59. Next key level to test is 0.88 - 0.93. Currently at 0.7 SAGT: Looking good on 4hours chart. Key support zone at 1.65 - 1.8. Next key level to test is 2.6 - 2.85. Currently at 2.16 VVPR: Alerted at 2.10 yesterday. Still looking good on 4hours chart. key support zone at 2 - 2.20. Next key level to test is 3.1 - 3.35. Currently at 2.60 LGHL: Getting up on 4hours chart. Key support zone at 1 - 1.10. Next key level to test is 1.95 - 2.15. Currently at 1.55
0 · Reply